Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-56170-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832594578433114112 |
|---|---|
| author | Salvatore Siena Kanwal Raghav Toshiki Masuishi Kensei Yamaguchi Tomohiro Nishina Elena Elez Javier Rodriguez Ian Chau Maria Di Bartolomeo Hisato Kawakami Fumitaka Suto Makito Koga Koichiro Inaki Yusuke Kuwahara Issey Takehara Daniel Barrios Kojiro Kobayashi Axel Grothey Takayuki Yoshino |
| author_facet | Salvatore Siena Kanwal Raghav Toshiki Masuishi Kensei Yamaguchi Tomohiro Nishina Elena Elez Javier Rodriguez Ian Chau Maria Di Bartolomeo Hisato Kawakami Fumitaka Suto Makito Koga Koichiro Inaki Yusuke Kuwahara Issey Takehara Daniel Barrios Kojiro Kobayashi Axel Grothey Takayuki Yoshino |
| author_sort | Salvatore Siena |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d16b7183fa7a4b67b386e3659ef208e2 |
| institution | Kabale University |
| issn | 2041-1723 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj-art-d16b7183fa7a4b67b386e3659ef208e22025-01-19T12:31:43ZengNature PortfolioNature Communications2041-17232025-01-011611110.1038/s41467-025-56170-9Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01Salvatore Siena0Kanwal Raghav1Toshiki Masuishi2Kensei Yamaguchi3Tomohiro Nishina4Elena Elez5Javier Rodriguez6Ian Chau7Maria Di Bartolomeo8Hisato Kawakami9Fumitaka Suto10Makito Koga11Koichiro Inaki12Yusuke Kuwahara13Issey Takehara14Daniel Barrios15Kojiro Kobayashi16Axel Grothey17Takayuki Yoshino18Department of Oncology and Hemato-Oncology, Università degli Studi di Milano and Niguarda Cancer Center, Grande Ospedale Metropolitano NiguardaDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartment of Clinical Oncology, Aichi Cancer Center HospitalThe Cancer Institute Hospital of JFCRNational Hospital Organization Shikoku Cancer CenterVall d’Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de BarcelonaMedical Oncology Department, Clinica Universidad de NavarraRoyal Marsden NHS Foundation TrustDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale TumoriKindai University HospitalDaiichi SankyoDaiichi Sankyo, Co., LtdDaiichi Sankyo, Co., LtdDaiichi SankyoDaiichi Sankyo, Co., LtdDaiichi SankyoDaiichi SankyoWest Cancer CenterNational Cancer Center Hospital Easthttps://doi.org/10.1038/s41467-025-56170-9 |
| spellingShingle | Salvatore Siena Kanwal Raghav Toshiki Masuishi Kensei Yamaguchi Tomohiro Nishina Elena Elez Javier Rodriguez Ian Chau Maria Di Bartolomeo Hisato Kawakami Fumitaka Suto Makito Koga Koichiro Inaki Yusuke Kuwahara Issey Takehara Daniel Barrios Kojiro Kobayashi Axel Grothey Takayuki Yoshino Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 Nature Communications |
| title | Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 |
| title_full | Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 |
| title_fullStr | Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 |
| title_full_unstemmed | Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 |
| title_short | Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 |
| title_sort | publisher correction her2 related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with her2 expressing metastatic colorectal cancer biomarker analyses of destiny crc01 |
| url | https://doi.org/10.1038/s41467-025-56170-9 |
| work_keys_str_mv | AT salvatoresiena publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT kanwalraghav publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT toshikimasuishi publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT kenseiyamaguchi publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT tomohironishina publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT elenaelez publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT javierrodriguez publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT ianchau publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT mariadibartolomeo publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT hisatokawakami publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT fumitakasuto publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT makitokoga publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT koichiroinaki publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT yusukekuwahara publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT isseytakehara publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT danielbarrios publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT kojirokobayashi publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT axelgrothey publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 AT takayukiyoshino publishercorrectionher2relatedbiomarkerspredictclinicaloutcomeswithtrastuzumabderuxtecantreatmentinpatientswithher2expressingmetastaticcolorectalcancerbiomarkeranalysesofdestinycrc01 |